EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multi-institutional European validation of a symptom based classification in renal cell carcinoma



Multi-institutional European validation of a symptom based classification in renal cell carcinoma



European Urology Supplements 3(2): 127, February




(PDF 0-2 workdays service: $29.90)

Accession: 035349246

Download citation: RISBibTeXText



Related references

Multi-institutional validation of a symptom based classification for renal cell carcinoma. Journal of Urology 172(3): 858-862, 2004

Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project). Scandinavian Journal of Urology 51(4): 269-276, 2017

Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed?. European Urology 58(4): 588-595, 2011

Re: Validation of the 2009 TNM Version in a Large Multi-Institutional Cohort of Patients Treated for Renal Cell Carcinoma: Are Further Improvements Needed?. Journal of Urology 185(4): 1223-1223, 2016

Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium. European Urology Focus, 2017

Validation of 2009 TNM classification based on a prognostic analysis of 350 patients treated for renal cell carcinoma. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 103(3): 540-547, 2012

Renal cell carcinoma in end-stage renal disease: Multi-institutional comparative analysis of survival. International Journal of Urology 23(6): 465-471, 2016

Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. Journal of Urology 181(3): 1004-12; Discussion 1012, 2009

Validation of the 2009 TNM Classification for Renal Cell Carcinoma: Comparison with the 2002 TNM Classification by Concordance Index. Korean Journal of Urology 52(8): 524-530, 2011

BAP1 immunohistochemistry predicts outcomes in a multi-institutional cohort with clear cell renal cell carcinoma. Journal of Urology 191(3): 603-610, 2014

Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma. Bju International 109(8): 1140-1146, 2012

Comparison of oncological outcomes of transperitoneal and retroperitoneal laparoscopic radical nephrectomy for the management of clear-cell renal cell carcinoma: a multi-institutional study. Bju International 107(9): 1467-1472, 2011

Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review. Journal of Urology 183(2): 460-466, 2010

Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers. International Journal of Urology 16(2): 187-191, 2008

Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers. Cancer 110(8): 1715-1722, 2007